Articles
Cochlear cleared to sell new device in US
The FDA has granted Cochlear (ASX:COH) approval to sell the Nucleus Hybrid L24 - a new cochlear implant system designed to address high-frequency hearing loss - in the US. [ + ]
Millennium-old frozen moss comes back to life
Researchers from the British Antarctic Survey and the University of Reading have demonstrated for the first time that after over 1500 years frozen in Antarctic ice, moss can come back to life and continue to grow. [ + ]
Ascend cancer drug shows potential in CBCL
More than 80% of patients with cutaneous B-cell lymphoma enrolled in a phase II trial of Ascend's in-licensed cancer drug ASN-002 demonstrated a complete or partial response to treatment. [ + ]
First evidence of cosmic inflation found
Researchers from the BICEP2 collaboration have announced the first direct evidence of cosmic inflation - the rapid expansion of the universe which immediately followed the Big Bang. Until now, the idea of this exponential expansion was just a theory. [ + ]
Virax to buy Pathway Oncology
Virax Holdings (ASX:VHL) has arranged to buy Pathway Oncology, a company with an exclusive licence to a cancer drug candidate due to enter phase II trials in breast cancer and multiple myeloma. [ + ]
Imugene kicks off IND process for HER-Vaxx
Imugene (ASX:IMU) has appointed Ground Zero Pharmaceuticals to help the company prepare its Investigational New Drug application with the US FDA for cancer vaccine HER-Vaxx. [ + ]
The best laid plans of mice in men
Scientists from the UK and Australia have created a mouse strain that expresses a fluorescing biosensor in every cell of its body, allowing diseased cells and drugs to be tracked and evaluated in real time. [ + ]
Rapid DNA profiling for FBI
IntegenX, a developer of rapid human DNA identification technology, has met the US FBI guidelines to upload directly to the National DNA Index System (NDIS) known arrestee and convicted offender DNA profiles, as well as casework known samples. The profiles will be generated with the RapidHIT System using Life Technologies GlobalFiler Express kits from Thermo Fisher Scientific. [ + ]
Mesoblast's new appointments "increase global visibility"
Mesoblast's (ASX:MSB) hiring of a former Novartis CFO so soon after former Roche executive William Burns joined its board may help the company pursue international partnership deals, Bell Potter said. [ + ]
GTG breast cancer test found to be cost-effective
Genetic Technologies (ASX:GTG) said economic modelling has shown the cost-effectiveness of using BREVAGen to help direct chemoprevention to women at elevated risk of breast cancer. [ + ]
China Summit paves the way for Australian companies
Recognising the leading role China will take globally in the future of life sciences, AusBiotech recently presented the second Australia China Life Science Summit in Sydney and now continues to pave the way for Australian companies interested in opportunities in and with China. [ + ]
Fibrotech completes phase Ia trial, moves to 1b
Fibrotech said a phase Ia trial has demonstrated the safety of antifibrotic candidate FT011 in healthy volunteers, and revealed the company has started dosing for a phase IIb study. [ + ]
Wireless monitoring systems for critical applications in life science facilities
Users need to be aware that not all monitoring systems are equal. Choosing the right system is paramount to product protection and adding value to your process. [ + ]
ESO telescope finds its MUSE
An innovative instrument called MUSE (Multi Unit Spectroscopic Explorer) has been successfully installed on the European Southern Observatory's (ESO) Very Large Telescope (VLT) at the Paranal Observatory in Chile. [ + ]
Biotron shares surge 123% on HIV/HCV trial data
Biotron (ASX:BIT) has announced promising additional early results from a trial of BIT225 in patients with both HIV and HCV. [ + ]
